Honokiol - Huons
Alternative Names: HL - Huons; HU-002Latest Information Update: 26 Jun 2024
At a glance
- Originator Huons
- Class Antibacterials; Antineoplastics; Antithrombotics; Anxiolytics; Biphenyl compounds; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Lipid modulators; Nerve growth factor receptor modulators; Xanthine oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Pulmonary hypertension
- No development reported Non-alcoholic fatty liver disease
Most Recent Events
- 17 May 2024 Preclinical trials in Pulmonary hypertension in South Korea (PO) before May 2024
- 17 May 2024 Pharmacodynamics data from a preclinical trial in Pulmonary hypertension presented at the 120th International Conference of the American Thoracic Society (ATS-2024)
- 28 Nov 2018 No recent reports of development identified for phase-II for Non-alcoholic fatty liver disease in South Korea (PO)